In breast carcinoma, chronic intermittent exposure to adriamycin induced hypermethylation that was associated with multidrug resistant phenotype in correlation to an upregulation of DNMT1, DNMT3A and DNMT3B and an increase in DNA methyltransferase activity [36]. The gene discussed is DNMT3A; the disease is breast carcinoma.